Literature DB >> 25443608

Regression of pulmonary artery hypertension due to development of a pulmonary arteriovenous malformation.

Ashfaq Hasan1, B K S Sastry2, M A Aleem3, Gokul Reddy4, Syed Mahmood5.   

Abstract

Idiopathic Pulmonary Hypertension (IPAH) is characterized by elevated pulmonary arterial pressure in the absence of an identifiable underlying cause. The condition is usually relentlessly progressive with a short survival in the absence of treatment.(1) We describe a patient of IPAH in whom the pulmonary artery pressures significantly abated with complete disappearance of symptoms, following spontaneous development of a pulmonary arterio-venous malformation (PAVM).
Copyright © 2014 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arterio-venous malformation; Hemoptysis; Pregnancy; Pulmonary arterial hypertension; Regression

Mesh：

Year:  2014        PMID： 25443608      PMCID： PMC4223210          DOI： 10.1016/j.ihj.2014.09.001

Source DB:  PubMed          Journal:  Indian Heart J        ISSN： 0019-4832


  12 in total

1.  PULMONARY ARTERIOVENOUS ANEURYSMS AND FISTULAS. ANATOMICAL VARIATIONS, EMBRYOLOGY, AND CLASSIFICATION.

Authors:  I N ANABTAWI; R G ELLISON; L T ELLISON
Journal:  Ann Thorac Surg       Date:  1965-05       Impact factor: 4.330

2.  Physiological alterations in increased pulmonary blood flow with and without pulmonary hypertension.

Authors:  L T ELLISON; D P HALL; T YEH; H MOBARHAN; J ROSSI; R G ELLISON
Journal:  J Appl Physiol       Date:  1961-03       Impact factor: 3.531

Review 3.  Pulmonary arteriovenous malformations. A state of the art review.

Authors:  J R Gossage; G Kanj
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

4.  A case of spontaneous resolution of idiopathic pulmonary hypertension.

Authors:  A Fujii; M Rabinovitch; E C Matthews
Journal:  Br Heart J       Date:  1981-11

5.  Pulmonary arteriovenous fistulas with pulmonary hypertension.

Authors:  D C Sperling; M Cheitlin; R W Sullivan; A Smith
Journal:  Chest       Date:  1977-06       Impact factor: 9.410

6.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

Authors:  R C Trembath; J R Thomson; R D Machado; N V Morgan; C Atkinson; I Winship; G Simonneau; N Galie; J E Loyd; M Humbert; W C Nichols; N W Morrell; J Berg; A Manes; J McGaughran; M Pauciulo; L Wheeler
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

7.  Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.

Authors:  Lewis J Rubin; David B Badesch; Thomas R Fleming; Nazzareno Galiè; Gerald Simonneau; Hossein A Ghofrani; Michael Oakes; Gary Layton; Marjana Serdarevic-Pehar; Vallerie V McLaughlin; Robyn J Barst
Journal:  Chest       Date:  2011-05-05       Impact factor: 9.410

8.  Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia.

Authors:  S A Abdalla; C J Gallione; R J Barst; E M Horn; J A Knowles; D A Marchuk; M Letarte; J H Morse
Journal:  Eur Respir J       Date:  2004-03       Impact factor: 16.671

9.  Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia.

Authors:  Omar A Minai; Christina Rigelsky; Charis Eng; Alejandro C Arroliga; James K Stoller
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

10.  Recruitment of arteriovenous pulmonary shunts may attenuate the development of pulmonary hypertension in dogs experimentally infected with Angiostrongylus vasorum.

Authors:  José M Matos; Manuela Schnyder; Rima Bektas; Mariano Makara; Annette Kutter; Simone Jenni; Peter Deplazes; Tony Glaus
Journal:  J Vet Cardiol       Date:  2012-05-08       Impact factor: 1.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.